ITIH5
Inter-alpha-trypsin inhibitor heavy chain H5
Also known as: ITIH5_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q86UX2
- Gene
- ITIH5
- Canonical length
- 942 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
OverviewNCBI Gene
No narrative summary is available for ITIH5 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
942 residues, UniProt reviewed canonical sequence.
>Q86UX2|ITIH5
1 MLLLLGLCLG LSLCVGSQEE AQSWGHSSEQ DGLRVPRQVR LLQRLKTKPL MTEFSVKSTI
61 ISRYAFTTVS CRMLNRASED QDIEFQMQIP AAAFITNFTM LIGDKVYQGE ITEREKKSGD
121 RVKEKRNKTT EENGEKGTEI FRASAVIPSK DKAAFFLSYE ELLQRRLGKY EHSISVRPQQ
181 LSGRLSVDVN ILESAGIASL EVLPLHNSRQ RGSGRGEDDS GPPPSTVINQ NETFANIIFK
241 PTVVQQARIA QNGILGDFII RYDVNREQSI GDIQVLNGYF VHYFAPKDLP PLPKNVVFVL
301 DSSASMVGTK LRQTKDALFT ILHDLRPQDR FSIIGFSNRI KVWKDHLISV TPDSIRDGKV
361 YIHHMSPTGG TDINGALQRA IRLLNKYVAH SGIGDRSVSL IVFLTDGKPT VGETHTLKIL
421 NNTREAARGQ VCIFTIGIGN DVDFRLLEKL SLENCGLTRR VHEEEDAGSQ LIGFYDEIRT
481 PLLSDIRIDY PPSSVVQATK TLFPNYFNGS EIIIAGKLVD RKLDHLHVEV TASNSKKFII
541 LKTDVPVRPQ KAGKDVTGSP RPGGDGEGDT NHIERLWSYL TTKELLSSWL QSDDEPEKER
601 LRQRAQALAV SYRFLTPFTS MKLRGPVPRM DGLEEAHGMS AAMGPEPVVQ SVRGAGTQPG
661 PLLKKPYQPR IKISKTSVDG DPHFVVDFPL SRLTVCFNID GQPGDILRLV SDHRDSGVTV
721 NGELIGAPAP PNGHKKQRTY LRTITILINK PERSYLEITP SRVILDGGDR LVLPCNQSVV
781 VGSWGLEVSV SANANVTVTI QGSIAFVILI HLYKKPAPFQ RHHLGFYIAN SEGLSSNCHG
841 LLGQFLNQDA RLTEDPAGPS QNLTHPLLLQ VGEGPEAVLT VKGHQVPVVW KQRKIYNGEE
901 QIDCWFARNN AAKLIDGEYK DYLAFHPFDT GMTLGQGMSR ELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITIH5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 106 nTPM
- placenta: 82 nTPM
- colon: 59 nTPM
- blood vessel: 59 nTPM
- urinary bladder: 53 nTPM
- breast: 51 nTPM
Single-cell type
- adipocytes: 524 nCPM
- cytotrophoblasts: 478 nCPM
- salivary ionocytes: 319 nCPM
- podocytes: 311 nCPM
- syncytiotrophoblasts: 300 nCPM
- fibro-adipogenic progenitors: 290 nCPM
Immune cell
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 45 nTPM
- thalamus: 32 nTPM
- pons: 26 nTPM
- cerebellum: 25 nTPM
- medulla oblongata: 23 nTPM
- basal ganglia: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.14
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- von Willebrand factor, type A
- Inter-alpha-trypsin inhibitor heavy chain, C-terminal
- VIT domain
- von Willebrand factor A-like domain superfamily
- Inter-alpha-trypsin inhibitor heavy chain
- von Willebrand factor type A domain
- Inter-alpha-trypsin inhibitor heavy chain C-terminus
- Vault protein inter-alpha-trypsin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITIH5 as an antibody target. Whether an autoantibody or antibody against ITIH5 could matter depends on whether native ITIH5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITIH5 is annotated as secreted, so native ITIH5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ITIH5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...